Evidence on the cost of breast cancer drugs is required for rational decision making

BACKGROUND: For rational decision making, assessing the cost-effectiveness and budget impact of new drugs and comparing the costs of drugs already on the market is required. In addition to value frameworks, such as the American Society of Clinical Oncology Value Framework and the European Society of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ecancermedicalscience
Hlavní autoři: Berghuis, Anne Margreet Sofie, Koffijberg, Hendrik, Terstappen, Leonardus Wendelinus Mathias Marie, Sleijfer, Stefan, IJzerman, Maarten Joost
Médium: Artigo
Jazyk:Inglês
Vydáno: Cancer Intelligence 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5931813/
https://ncbi.nlm.nih.gov/pubmed/29743945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.825
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky